Effects of lacosamide and carbamazepine on lipids in a randomized trial.
Scott MintzerSvetlana DimovaYing ZhangBjörn Steiniger-BrachMarc De BackerDaya ChellunRobert RoeblingPublished in: Epilepsia (2020)
This study provides Class II evidence that CBZ elevates serum lipids, whereas LCM has no effect on lipids. It supports LCM as an appropriate choice for new-onset focal epilepsy.
Keyphrases